Citation Impact
Citing Papers
Histocompatible Embryonic Stem Cells by Parthenogenesis
2006 Science
Metastasis: from dissemination to organ-specific colonization
2009 Standout
Differential Serum Levels of Eosinophilic Eotaxins in Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, and Autoimmune Hepatitis
2013 StandoutNobel
Guidelines for the welfare and use of animals in cancer research
2010 Standout
Effluxing ABC transporters in human corneal epithelium
2009
Characterization of the Overlap Syndrome of Primary Biliary Cirrhosis (Pbc) and Autoimmune Hepatitis: Evidence for It Being A Hepatitic Form of Pbc in Genetically Susceptible Individuals
1999
Quercetin and chrysin inhibit nickel-induced invasion and migration by downregulation of TLR4/NF-κB signaling in A549 cells
2018
A statistical analysis of in vitro human microsomal metabolic stability of small phenyl group substituents, leading to improved design sets for parallel SAR exploration of a chemical series
2010
Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis
1989
Ethoxyfagaronine, a synthetic analogue of fagaronine that inhibits vascular endothelial growth factor-1, as a new anti-angiogeneic agent
2014 StandoutNobel
The influence of drug-like concepts on decision-making in medicinal chemistry
2007 Standout
Strategies and New Developments in the Generation of Patient-Specific Pluripotent Stem Cells
2007 StandoutNobel
Site-directed mutagenesis of lysine within the immunodominant autoepitope of PDC-E2
1990
A Review on Central Nervous System Effects of Gastrodin
2018 Standout
Cancer to bone: a fatal attraction
2011 Standout
Autoantibodies to mitochondria in systemic sclerosis. frequency and characterization using recombinant cloned autoantigen
1988
Mechanisms involved in the transport of mercuric ions in target tissues
2016
Familial Primary Biliary Cirrhosis in Hiroshima
1999
Use of A Designer Triple Expression Hybrid Clone for Three Different Lipoyl Domain for the Detection of Antimitochondrial Autoantibodies
1996
Efflux of Depsipeptide FK228 (FR901228, NSC-630176) Is Mediated by P-Glycoprotein and Multidrug Resistance-Associated Protein 1
2005
NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF
2006
Evaluation of a series of bicyclic CXCR2 antagonists
2007
Frequency of IgG and IgM autoantibodies to four specific M2 mitochondrial autoantigens in primary biliary cirrhosis
1989
Structure and function of the blood–brain barrier
2009 Standout
ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets
2006
Pulmonary fibrosis: pathogenesis, etiology and regulation
2009 Standout
Synthesis and structure–activity relationships of new disubstituted phenyl-containing 3,4-diamino-3-cyclobutene-1,2-diones as CXCR2 receptor antagonists
2008
Ocular Drug Delivery
2010 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Discovery of a potent respiratory syncytial virus RNA polymerase inhibitor
2013
In vivo toxicity studies of fusarium mycotoxins in the last decade: A review
2015 Standout
Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic
2021 Standout
Characterization of antimitochondrial antibodies in healthy adults
1998
Pathogenesis of primary biliary cirrhosis
2003
Anti-pyruvate dehydrogenase autoantibodies in primary biliary cirrhosis
1991
THP-1 cell line: An in vitro cell model for immune modulation approach
2014 Standout
Antimitochondrial Antibodies in Kindreds of Patients With Primary Biliary Cirrhosis: Antimitochondrial Antibodies Are Unique to Clinical Disease and Are Absent in Asymptomatic Family Members
1992
Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?
2011 Standout
IKK/NF- B signaling: balancing life and death - a new approach to cancer therapy
2005 Standout
Nuclear Transfer and iPS May Work Best Together
2008 StandoutNobel
Discovery of small molecule human C5a receptor antagonists
2009
Designing hydrogels for controlled drug delivery
2016 Standout
Transcriptional profiling of the LPS induced NF-κB response in macrophages
2007
Autoantibodies against a 210kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis
1998
Low specificity of anti‐tissue transglutaminase antibodies in patients with primary biliary cirrhosis
2006
The use of spirocyclic scaffolds in drug discovery
2014 Standout
Microtubule-binding agents: a dynamic field of cancer therapeutics
2010 Standout
PROTAC targeted protein degraders: the past is prologue
2022 Standout
Sarcoidosis
1997 Standout
European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease
2011 Standout
Primary Biliary Cirrhosis
1996
Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.
1993
Features of Selective Kinase Inhibitors
2005
Primary biliary cirrhosis: Paradigm or paradox for autoimmunity
1991
A selective novel low‐molecular‐weight inhibitor of IκB kinase‐β (IKK‐β) prevents pulmonary inflammation and shows broad anti‐inflammatory activity
2005
Quantitative Measurement of Autoantibodies to Recombinant Mitochondrial Antigens in Patients With Primary Biliary Cirrhosis: Relationship of Levels of Autoantibodies to Disease Progression
1997
Transport of Inorganic Mercury and Methylmercury in Target Tissues and Organs
2010
Role of YAP/TAZ in mechanotransduction
2011 StandoutNature
An analysis of the attrition of drug candidates from four major pharmaceutical companies
2015 Standout
Drug metabolism and pharmacokinetics, the blood-brain barrier, and central nervous system drug discovery
2005
Epitope mapping and reactivity of autoantibodies to the E2 component of 2-oxoglutarate dehydrogenase complex in primary biliary cirrhosis using recombinant 2-oxoglutarate dehydrogenase complex
1996
Detection of Antimitochondrial Antibodies: Characterization by Enzyme Immunoassay and Immunoblotting
1989
Rings in Drugs
2014 Standout
Fluorine in medicinal chemistry
2007 Standout
Supramolecular biomaterials
2015 Standout
Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations
2018
Self-Assembled Tat Nanofibers as Effective Drug Carrier and Transporter
2013
The Medicinal Chemist’s Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates
2011 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Primary Biliary Cirrhosis
2011 Standout
Oxadiazoles in Medicinal Chemistry
2011 Standout
From the Gut to the Brain: Journey and Pathophysiological Effects of the Food-Associated Trichothecene Mycotoxin Deoxynivalenol
2013
The Interleukin-8 Pathway in Cancer
2008 Standout
Heavy Metals and Human Health: Mechanistic Insight into Toxicity and Counter Defense System of Antioxidants
2015 Standout
Detection of Anti-branched Chain 2-0xo Acid Dehydrogenase Complex (BCOADC)-E2 Antibody in Primary Biliary Cirrhosis by ELISA using Recombinant Fusion Protein
1999
Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis
1993
5 Immunopathology of primary biliary cirrhosis
1996
Generation of a Set of Simple, Interpretable ADMET Rules of Thumb
2008
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Administration of substances to laboratory animals: routes of administration and factors to consider.
2011 Standout
M4 and M9 Antibodies in the Overlap Syndrome of Primary Biliary Cirrhosis and Chronic Active Hepatitis: Epitopes or Epiphenomena?
1992
Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis.
1990 StandoutNobel
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
2009 Standout
Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochondrial antibody-negative primary biliary cirrhosis
1995
ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties
2021 Standout
Generation of biliary lesions after transfer of human lymphocytes into severe combined immunodeficient (SCID) mice.
1989
Chemistry and Biology Of Multicomponent Reactions
2012 Standout
Applications of Fluorine in Medicinal Chemistry
2015 Standout
Chemical Chaperones Reduce ER Stress and Restore Glucose Homeostasis in a Mouse Model of Type 2 Diabetes
2006 StandoutScience
Principles and Applications of Halogen Bonding in Medicinal Chemistry and Chemical Biology
2012 Standout
Classification of chronic hepatitis: Diagnosis, grading and staging
1994 Standout
Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.
1994
Works of Anne Cooper being referenced
Differential Multidrug Resistance-Associated Protein 1 through 6 Isoform Expression and Function in Human Intestinal Epithelial Caco-2 Cells
2004
The Influence of DMPK as an Integrated Partner in Modern Drug Discovery
2002
Detection of Autoantibodies to Recombinant Mitochondrial Proteins in Patients with Primary Biliary Cirrhosis
1989
Optimisation of DMPK by the Inhaled Route: Challenges and Approaches
2012
Hit-to-Lead studies: The discovery of potent, orally bioavailable triazolethiol CXCR2 receptor antagonists
2003
Modulators of the human CCR5 receptor. Part 3: SAR of substituted 1-[3-(4-methanesulfonylphenyl)-3-phenylpropyl]-piperidinyl phenylacetamides
2006
Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors
2004
Modulators of the human CCR5 receptor. Part 2: SAR of substituted 1-(3,3-diphenylpropyl)-piperidinyl phenylacetamides
2005
The predominance of IgG3 and IgM isotype antimitochondrial autoantibodies against recombinant fused mitochondrial polypeptide in patients with primary biliary cirrhosis
1988
Hit-to-Lead studies: The discovery of potent, orally bioavailable thiazolopyrimidine CXCR2 receptor antagonists
2005